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Abstract Systematic review (SR) and meta-analysis (MA)
have potential to contribute substantially to environmental
health (EH) risk assessment and policy-making, provided
study questions are clear and methods sound. We undertook
a systematic review of the published epidemiological litera-
ture for studies using both SR andMA examining associations
between chronic low-dose chemical exposures and adverse
health outcomes in general populations and compared actual
methods and reporting with a checklist based on available
published guidelines. We identified 48 EH SRMAs meeting
these criteria. Associations were mainly positive and statisti-
cally significant, often involving large populations. Amajority
of studies followed most general SRMA guidance, although
we identified weaknesses in problem formulation, study
search, selection and data extraction, and integrating policy
implications. Fewer studies followed EH-specific SRMA rec-
ommendations, particularly regarding exposure heterogeneity
and other risks of bias. Development and adoption of EH-
specific SRMA guidelines would contribute to strengthening
these tools for public health decision-making.
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Introduction
The World Health Organization (WHO) estimates that
environmental factors are responsible for at least one
quarter of the global burden of disease [1]. A growing
body of evidence suggests a considerable share stems
from exposure to environmental chemicals [2]; in many
cases, such exposures are widespread across large pop-
ulations or involve vulnerable groups [2, 3]. Preventing
environmentally related disease requires the translation
of up-to-date scientific research into accessible evidence
that informs environmental health (EH) risk assessment,
policy formulation, health care practice, and individual
health behaviors [4, 5]. However, the scientific literature
is diverse, of varying quality, and often not easily ac-
cessible to decision-makers [6].
The tools of evidence-based science — systematic
review (a literature review that poses a well-defined
and specific research question, uses systematic and ex-
plicit methods to identify, select and appraise research,
and analyze data from selected studies) and meta-
analysis (a quantitative statistical analysis that integrates
results of chosen studies) [7] — are well-developed for
randomized controlled trials and making recommenda-
tions in clinical medicine. These tools also have the
potential to play a role in EH risk assessment and pol-
icy-making. When used together, systematic review and
meta-analysis (SRMA) techniques provide rigorous rules
designed to gather all relevant research on a well-
defined study question, statistically pool outcomes
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across studies with comparable methods, and provide a
transparent, thorough, and replicable examination of
available evidence. This can help to overcome the draw-
backs of small sample size, demonstrate where effects
are consistent across studies and generalizable across
populations and where they are not, minimize bias and
reduce chance effects, and identify research gaps [8].
EH science evidence with these features can help facil-
itate efficient policy-making.
Human epidemiological studies are the preferred
body of evidence for EH, as they represent real-world
background and co-exposures and do not require species
extrapolation. However, in practice, the observational
designs of human epidemiological studies in EH pose
challenges to conducting MA that have contributed to
slower adoption of SRMA. Among these are inability to
fully control for confounders at all times, inconsis-
tencies across studies in exposure measurement methods
and metrics, and differences in outcomes, populations,
and study designs [9]. Development of special meta-
analytical methods to control for confounding [10] and
risk-of-bias assessment checklists [11] have contributed
to improving SRMA methods for observational studies.
Codification of reporting guidance, such as the Meta-
Analysis of Observational Studies in Epidemiology
(MOOSE) consensus statement [12], has also advanced
the field; use of such guidelines is associated with
higher quality reporting [13]. More recently, the US
National Institutes of Environmental Health Sciences
(NIEHS) National Toxicology Program (NTP) has
adopted SRMA in its chemical assessments [14•]; the
US EPA is examining using these tools for risk assess-
ment under its Integrated Risk Information System
(IRIS) program [15•]; and the Navigation Guide group
(an interdisciplinary collaboration between academicians,
practitioners, and clinicians) has developed a framework
to assess the strength of EH science evidence [16, 17•].
These newer initiatives are contributing to the refine-
ment and codification of methodological approaches
for SRMA tailored to the specificities of EH.
The potential of SRMA to contribute to EH policy,
the development of more robust, EH-specific methods,
and growing interest in their use suggest the need to
take stock of the nature and quality of the current body
of published EH SRMAs. We undertook a systematic
review of the EH literature to identify SRMA studies
examining associations between chronic low-dose chem-
ical exposures and adverse health outcomes in general
human populations in order to compare methods used
with available published consensus reporting guidelines.
The broad goal of this review is to contribute to en-
hancing the utility and expanding use of these powerful
evidence-synthesis tools for EH policy.
Methods
We conducted a search of the published scientific literature
using Medline, Embase, Web of Science, Scopus, and Google
Scholar (with the search terms Benvironment^ OR Bpollutant^
OR Bcontaminant^ AND Bdisease^ OR Bchronic AND
disease^ OR Bhealth AND effects^ AND Bsystematic^ AND
Breview^ AND Bmeta-analysis^ OR Bmeta AND analysis^
OR Bquantitative AND analysis,^ screened for human studies
only). We performed topic searches in these electronic data-
bases examining keywords, titles, and abstracts for designated
terms and also hand-searched reference lists of selected stud-
ies.We did not restrict by language or starting date. Our search
end date was June 30, 2013. We screened all titles and ab-
stracts identified and reviewed full texts of articles that met
prespecified inclusion criteria. We included only studies
employing both SR and MA. We did not include SRs done
without MA (e.g., SRs done as scoping reviews, SRs without
quantitative outcomes, or SRs where reported outcomes were
inadequate for a statistical analysis) or MAs for which SR had
not been conducted (e.g., MA used to combine results across
multicenter epidemiological studies or dose-response assess-
ment using MA based on a few specifically chosen studies
rather than a SR). We included SRMAs examining general,
non-occupationally exposed populations exposed to
chemicals at chronic, low dose (excluding biological, mental,
or physical exposures, accidental high-dose acute exposures,
intentional exposures such as alcohol or tobacco, and second-
hand smoke exposure) that examined associations with one or
more adverse health effects.
Both authors independently extracted data from included
studies (differences were resolved by consensus), using
purpose-designed data extraction forms previously tested on
a pilot group of reviews. Extracted data included study goal,
population characteristics, environmental exposures and their
measurement protocols, health outcomes and their ascertain-
ment procedures, summary effect measures (with confidence
bounds), and responses to a checklist of 61 parameters of
study methodological and reporting quality. We developed
the checklist based on guidelines for SRMAs available to
researchers during our review period, including the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement [7], the MOOSE statement [11], and
guidelines for use of SRMA in environmental epidemiology
resulting from a 1994 workshop (referred to as BBlair et al.^)
[18]. Checklist items for the general features of SRMAwere
based primarily on the PRISMA and MOOSE statements,
while those related to quality and risk-of-bias evaluation, het-
erogeneity testing, exposure measurement, and outcome as-
certainment were also based on Blair et al. The checklist ques-
tions were designed to have up to five possible responses: yes
(Y), consistent with guideline; partial (P), in some part con-
sistent with guideline; no (N), inconsistent with guideline;
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cannot determine based on data (ND); and not applicable to
study (NA). For each parameter, definitions corresponding to
guideline recommendations were developed beforehand to fa-
cilitate consistency in reviewer data extraction (available in
Supplement 1). Responses were coded and combined in
Microsoft Excel and transferred to STATA version 10.0
(StataCorp, College Station, TX).
Results
Our search identified 1136 articles, of which the full texts for
146 were reviewed and 48 were selected (Fig. 1 and Table 1,
details in Supplement 1). All except two SRMAs were pub-
lished after 2000, the year the MOOSE guidelines were is-
sued; two thirds were published after 2009, the year the
PRISMA guidelines were published (Fig. 2). Selected reviews
covered a total of 16 chemicals or classes of chemicals, in five
categories: (i) 11 reviews of indoor air pollution (IAP),
consisting of various types of solid fuel smoke [19–29]; (ii)
12 reviews of various outdoor air pollution (OAP) constitu-
ents [30–41]; (iii) 10 reviews of metals [42–51]; (iv) seven
reviews of persistent organic pollutants (POPs) [52–58]; and
(v) eight reviews of other chemicals [59–66].
Associations with 28 health outcomes were explored, in
five categories: (i) cancers, including bladder, breast, colorec-
tal, lung, prostate, and childhood leukemia (27 % of reviews);
(ii) non-cancer respiratory diseases, including childhood asth-
ma, childhood pneumonia, chronic obstructive pulmonary
disease (COPD), tuberculosis, and acute respiratory infection
(21 %); (iii) reproductive and development disorders, includ-
ing birth defects, poor birth outcomes, and developmental
neurotoxicity (19 %); (iv) cardiovascular disease (CVD), in-
cluding hypertension, myocardial infarction, stroke, and heart
rate variability (19 %); and (v) other health outcomes, includ-
ing Parkinson’s disease, multiple sclerosis, and general mor-
tality (14 %).
Adults were assessed in 63 % of SRMAs, while infants or
children alone or in combination with women were the focus
of 37 % of reviews. Most reviews did not limit geographic
coverage; however, the majority of underlying study popula-
tions were from North America, Europe, and/or Asia. Thirty-
eight percent of reviews examined primarily (but not exclu-
sively) case-control studies, 27 % primarily cohort studies,
16 % primarily cross-sectional studies, 6 % time series and
case-crossover studies, and 13 % examined a mix in which no
study design was preponderant. Sixty percent of selected
SRMAs reported pooled odds ratios (ORs); one quarter re-
ported pooled relative risks (RRs), and the remainder reported
other measures. Information on funding sources was provided
in 67 % of SRMAs. Where this information was provided,
reviews were sponsored either by academic organizations
(63 %) or government bodies (37 %). Conflict of interest
statements were provided by about half of studies; most of
these declared no conflict.
SRMA Findings by Chemical Category
Indoor Air Pollution The IAP SRMAs examined exposures
due to smoke from solid fuels (coal, wood, animal dung, crop
wastes) used in cooking and heating, mainly in Africa, Latin
America, and Asia, with one study examining formaldehyde
exposure. Nearly three quarters examined respiratory out-
comes, and one quarter investigated cancers (mainly lung can-
cer) or other outcomes (Table 1). Among statistically signifi-
cant findings of the largest magnitude, three SRMAs examin-
ing coal smoke exposure and lung cancer in adults reported
ORs of 2.15 (95 % CI 1.61, 2.89, n=25) [20], 1.82 (95 % CI
1.60, 2.06, n=23) [23], and 2.66 (95 % CI 1.39, 5.07, n=8)
[25]. Three reviews of solid fuel smoke exposure and COPD
in adults found pooled ORs of 2.44 (95 % CI 1.79, 3.33, n=
15) [21], 2.80 (95 % CI 1.85, 4.00, n=12) [22], and 2.40
(95 % CI 1.47, 3.93, n=6) [25]. Two reviews of children
<5 years old examining solid fuel smoke exposure and respi-
ratory infection found combined ORs of 2.51 (95 % CI 1.53,
4.10, n=9) [24] and 3.53 (95 % CI 1.94, 6.43, n=10) [25],
while one review of solid fuel smoke and childhood pneumo-
nia found an OR of 1.79 (95 % CI 1.26, 2.21, n=24) [19].
Outdoor Air Pollution The OAP SRMAs examined expo-
sures including carbon monoxide (CO), ozone (O3), sulfur
dioxide (SO2), nitrogen dioxide (NO2), particulate matter
<2.5μm (PM2.5) and <10 μm (PM10) in various combinations
in large urban areas. Over 40 % evaluated CVD outcomes,
and the remainder respiratory, and reproductive and develop-
ment outcomes (Table 1). Among statistically significant as-
sociations of largest magnitude, an incremental 10 μg/m3 of
PM2.5 was associated with various cardiovascular outcomes,
including cardiovascular mortality (RR 1.15; 95 % CI 1.04,
1.27; n=10) [31]; heart failure (RR 1.02; 95 % CI 1.01, 1.02,
n=10) [36]; myocardial infarction (RR 1.03; 95 % CI 1.02,
1.04; n=13) [34]; and lower heart rate variability (decrease of
2.44 %, 95 % CI 3.76 %, 1.12 %, n=13) [35].
Metals The metal SRMAs covered exposure to arsenic, lead,
manganese, and mercury through various exposure pathways,
mainly in the USA and Asia. Forty percent of reviews exam-
ined cardiovascular outcomes and the remainder a range of
others (Table 1). Among statistically significant associations
of the largest magnitude were arsenic exposure in drinking
water (comparing high to low dose) and various
cardiovascular-related outcomes, including CVD (RR 1.32;
95 % CI 1.05, 1.67, n=18) [47]; diabetes type 2 (OR 2.52;
95 % CI 1.69, 3.75, n=6) [48] (this meta-analysis was restrict-
ed to populations with high arsenic exposure from Taiwan and
274 Curr Envir Health Rpt (2015) 2:272–283
Bangladesh), and hypertension (OR 1.27; 95 % CI 1.09, 1.47,
n=8) [42].
Persistent Organic Pollutants The POP SRMAs covered
residential pesticide exposure, the DDT metabolite DDE,
and mixed POPs. Nearly 70 % of reviews evaluated cancers
and the remainder other outcomes (Table 1). Among statisti-
cally significant associations of largest magnitude, three re-
views of residential pesticide exposure in utero and childhood
leukemia found pooledORs of 1.30 (95%CI 0.86, 1.97, n=4)
[53] and 2.05 (95 % CI 1.80, 2.32, n=11) [56] and RR of 2.19
(95 % CI 1.92, 2.50, n=13) [57]. One review found an appar-
ent lack of association between DDE and breast cancer in
women (OR 0.97; 95 % CI 0.87, 1.09, n=21) [54].
Other Chemicals The other chemical SRMAs examined ex-
posure to disinfection by-products and fluoride in drinking
water and exposure to hair dye. Nearly 70 % of reviews ex-
amined cancers, and the remainder involved other outcomes
(Table 1). Among observed statistically significant associa-
tions of largest magnitude were disinfection by-products and
various cancers, including of the bladder (RR 1.21; 95 % CI
1.09, 1.34, n=7; and OR 1.4; 95 % CI 1.2, 1.7, n=8) [62, 66];
rectum (RR 1.4; 95% CI 1.2, 1.7, n=6; and RR 1.30; 95 % CI
1.06, 1.59, n=10) [62, 64]; and colon (RR 1.27; 95% CI 1.08,
1.50, n=10) [64]. In addition, one SRMA found a null asso-
ciation between disinfection by-products and both low birth
weight (RR 1.0; 95 % CI 0.97, 1.03, n=4) and small for
gestational age (RR 1.01 95 % CI 1.00, 1.02, n=6) [60].
Comparison of Methods to Guidelines
Study Background andGoalAs shown in Supplement 2, the
vast majority of reviews (94 %) outlined the public health
problem and identified a study goal or research question; how-
ever, just 54% defined the goal or question sufficiently clearly
to identify all recommended elements (population, health out-
come, chemical exposure, and type of study) of a goal state-
ment. Only 40 % of titles self-identified as both SR and MA
(an additional 50% identified as one or the other). One quarter
referred to the use of an SRMA guideline; all of these referred
either to the PRISMA or MOOSE statements. Only 8 % of
reviews reported having an ex-ante study protocol or plan.
Search, Selection, and Extraction Virtually all reviews re-
ported on the electronic databases used to identify studies. Of
Fig. 1 Systematic review of environmental health (EH) epidemiology systematic review andmeta-analyses (SRMA): search and selection flow diagram
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Table 1 Systematic review of environmental health (EH) epidemiology systematic review and meta-analyses (SRMA): characteristics of selected
studies
Study reference Chemical Category Health outcome Population Pooled estimatea
Indoor air pollution (IAP)
Zhao et al. 2006 Coal smoke CANC Lung Adults OR 2.66 (1.39, 5.07)
Hosgood et al. 2011 Coal smoke CANC Lung Adults OR 2.15 (1.61, 2.89)
Kurmi et al. 2012 Coal smoke CANC Lung Adults OR 1.82 (1.60, 2.06)
Dherani et al. 2008 Solid fuel smoke RESP Pneumonia Children<5 OR 1.78 (1.45, 2.18)
Kurmi et al. 2010 Solid fuel smoke RESP COPD Adults OR 2.80 (1.85, 4.00)
McGwin et al. 2010 Formaldehyde RESP Asthma Children OR 1.17 (1.01, 1.36)
Hu et al. 2010 Biomass smoke RESP COPD Adults OR 2.44 (1.79, 3.33)
Po et al. 2011 Biomass smoke RESP ARI Children<5 OR 3.53 (1.94, 6.43)
Misra et al. 2012 Solid fuel smoke RESP ARI Children<5 OR 2.51 (1.53, 4.10)
Sumpter et al. 2013 Solid fuel smoke RESP Tuberculosis Adults OR 1.30 (1.04, 1.62)
Pope et al. 2010 Solid fuel smoke REPDEV Low birth weight Infants OR 1.38 (1.25, 1.52)
Outdoor air pollution (OAP)
Chen et al. 2008 PM2.5 CANC Lung Adults RR 1.21 (1.10, 1.32)
Mustafic et al. 2011 PM2.5 CVD Myocardial infarction Adults RR 1.03 (1.02, 1.04)
Pieters et al. 2012 PM2.5 CVD Heart rate variability Adults % −2.44 (−3.76, −1.12)
Li et al. 2012 PM2.5 CVD Stroke Adults RR 1.01 (1.00, 1.01)
Shah et al. 2013 PM2.5 CVD Heart failure Adults RR 1.016 (1.008, 1.023)
Hoek et al. 2013 PM2.5 CVD CVD mortality Adults RR 1.15 (1.04, 1.27)
Shang et al. 2013 PM2.5 RESP Respiratory mortality Adults RR 0.51 (0.30, 0.73)
Ward et al. 2004 PM2.5 RESP Peak expiratory flow Children % −0.144 (−0.243, −0.044)
Weinmayr et al. 2010 NO2 RESP Asthma symptoms Children OR 1.031 (1.001, 1.062)
Vrijheid et al. 2011 NO2 REPDEV Congenital anomalies Infants OR 1.20 (1.02, 1.42)
Stieb et al. 2012 PM10 REPDEV Low birth weight Infants OR 1.10 (1.05, 1.15)
Ito et al. 2005 Ozone OTHER All-cause mortality Adults % 1.6 (1.1, 2.0)
Metals
Chu et al. 2006 Arsenic CANC Bladder Adults Slope factor 3×10−5
Mink et al. 2008 Arsenic CANC Bladder Adults RR 1.11 (0.95, 1.30)
Navas-Acien et al. 2008 Lead CVD Hypertension Adults OR 1.04 (1.01, 1.07)
Gallagher et al. 2010 Cadmium CVD Diastolic BP Women Beta 1.84 (0.95, 2.74)
Abhyankar et al. 2011 Arsenic CVD Hypertension Adults OR 1.27 (1.09, 1.47)
Moon et al. 2012 Arsenic CVD Multiple CVD outcomes Adults RR 1.32 (1.05, 1.67)
Pocock et al. 1994 Lead REPDEV IQ point loss Children<5 −2.53 (−3.33, −1.73)
Rodriguez-Barranco et al. 2013 Arsenic REPDEV IQ point loss Children<5 −0.39 (−0.84, 0.06)
Navas-Acien et al. 2006 Arsenic OTHER Diabetes type 2 Adults OR 2.52 (1.69–3.75)
Aminzadeh et al. 2007 Mercury OTHER Multiple sclerosis Adults OR 1.24 (0.96, 1.61)
Persistent organic pollutants (POPs)
Lopez-Cervantes et al. 2004 DDE CANC Breast Women OR 0.97 (0.87, 1.09)
Turner et al. 2010 Pesticides CANC Child leukemia Children<5 OR 1.54 (1.13, 2.11)
Van Maele-Fabry et al. 2011 Pesticides CANC Child leukemia Children<5 OR 1.74 (1.37, 2.21)
Bailey et al. 2011 Pesticides CANC Child leukemia Children<5 OR 1.37 (1.00, 1.88)
Priyadarshi et al. 2001 Pesticides OTHER Parkinson’s disease Adults OR 1.85 (1.31, 2.60)
Allen et al. 2013 Pesticides OTHER Parkinson’s disease Adults OR 1.36 (1.05, 1.75)
Wu et al. 2013 PCBs OTHER Diabetes type 2 Adults 1.70 (1.28, 2.27)
Other
Morris et al. 1992 DBP CANC Bladder Adults OR 1.21 (1.09, 1.34)
Villanueva et al. 2003 DBP CANC Bladder Adults OR 1.4 (1.2, 1.7)
Takkouche et al. 2005 Hair dye CANC Hemopoietic Adults RR 1.15 (1.05, 1.27)
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these, 62 % conducted a wide search (defined as >3 data-
bases); however, in 19 % of reviews, authors limited their
search to one database. Medline was the most commonly used
database (cited by 96 % of reviews). Most (73 %) reviews
reported undertaking hand-searching. An extensive search pe-
riod (defined as >10 years) was covered in 64 % of reviews.
Language was unrestricted in 29 % of reviews, while the grey
literature was reported as searched in just 27 % of reviews.
Most (80 %) reviews presented key words used in the search
or the actual search terms for at least one database. While a
large majority (90 %) of reviews cited ex-ante study inclusion
or exclusion criteria, less than half (48 %) fully described the
screening, text review, and selection processes (though an
additional 19 % provided partial description of at least one
element of these processes). All relevant study designs were
deemed to be included in 70 % of reviews. Efforts to avoid
overlapping populations were described in 42% of reviews. A
small minority of reviews excluded studies due to low power
(14 %) or poor methods (18 %). A PRISMA-type study selec-
tion flow diagram was provided in 38 % of studies.
Study selection and/or data extraction was reported as being
done by two or more independent reviewers in over half
(54%) of reviews; in 42% of SRMAs, no statement was made
regarding the number of reviewers. All 48 reviews provided
effect point estimates along with measures of variance extract-
ed from underlying studies. In nearly all (92 %) reviews, data
on major underlying study covariates were also extracted. In a
majority (71 %) of reviews, extracted point estimates were
adjusted for commonly reported covariates; however, these
often varied across studies. Calculations performed by review
authors to derive comparable effect estimates were described
in 65 % of reviews. Information on health outcome ascertain-
ment and exposure measurement was extracted by most
(79 %) reviews. Authors of underlying studies were contacted
for additional information in the case of 27 % of reviews, and
13 % of reviews described using purpose-designed data ex-
traction forms.
Methods The large majority of reviews (94 %) reported using
a statistical test of heterogeneity, most commonly the I2
Table 1 (continued)
Study reference Chemical Category Health outcome Population Pooled estimatea
Rahman et al. 2010 DBP CANC Rectal Adults RR 1.30 (1.06, 1.59)
Hwang et al. 2003 DBP REPDEV Any birth defects Infants OR 1.25 (1.11, 1.40)
Nieuwenhuijsen et al. 2009 DBP REPDEV Any birth defects Infant OR 1.17 (1.02, 1.34)
Grellier et al. 2010 THM REPDEV SGA Infants OR 1.01 (1.00, 1.02)
Choi et al. 2013 Fluoride REPDEV IQ point loss Infants Diff. −0.45 (−0.56, −0.35)
a Pooled effect sizes shown are the principal chemical exposure and health effect associations reported in reviews (where more than one association was
examined, the association shown is that with the largest number of underlying studies or with the strongest identified association among those with
similar numbers of studies). Fuller results are reported in SupplementalMaterial File 1. Estimates compare exposed with unexposed or higher with lower
exposure groups, or provide risk per unit of pollutant
ARI acute respiratory infection, CANC cancer, COPD chronic obstructive pulmonary disease, CVD cardiovascular disease, DDE
dichlorodiphenyldichloroethylene, DBP disinfection by-products, IQ intelligence quotient, NO2 nitrogen dioxide, PCBs polychorinated biphenyls,
PM2.5 particulate matter<2.5 μm, REPDEV reproductive/developmental, RESP respiratory, SGA small for gestational age, THM trihalomethane
Fig. 2 Systematic review of
environmental health (EH)
epidemiology systematic review
and meta-analyses (SRMA): EH
SRMAs by publication year and
chemical category
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statistic. Moderate to substantial heterogeneity (e.g., I2>50%)
was found in more than half of SRMAs. Most reviews
employed a random-effect model in the presence of observed
heterogeneity. Sources of heterogeneity were explored
through stratification and/or meta-regression in 71 % of re-
views. We assessed health outcomes of underlying studies to
be the same or substantially similar (e.g., same ICD code or
same definition and ascertainment process) in 83% of reviews
and similar enough to be reasonably compared (e.g., similar
definition and ascertainment process) in an additional 13 %.
Outcome ascertainment relied predominantly on self-report in
nearly one third of reviews.
We assessed exposure metrics to be the same or substan-
tially similar (e.g., the same chemical and measurement tech-
nique, with similar exposure conditions) in 31 % of studies
and similar enough to be reasonably compared (the same or
similar chemical, similar measurement technique, and similar
exposure conditions) in an additional 65 % of reviews. In the
case of 40% of reviews, efforts had beenmade to convert non-
similar to similar exposure metrics based on clearly stated
assumptions. In addition, based on Blair et al. (1995) our
checklist identified four desirable exposure metric character-
istics, i.e., that measures preferably be (i) direct (rather than
proxy); (ii) individual; (iii) quantitative; and (iv) not based on
self-report. Our assessment of exposure measurement charac-
teristics reported in SRMAs was based on the preponderance
of evidence (i.e., greater than half of underlying studies meet-
ing the criteria). Results suggest that exposure measures were
primarily direct in 44% of the 48 SRMAs, individual in 52%,
quantitative in 58 %, and avoided self-report in 44 %. Expo-
sure heterogeneity was raised as a risk-of-bias concern in the
Discussion sections of 77 % of reviews.
A formal quality and/or risk-of-bias evaluation was report-
ed to have been undertaken in 38% of reviews, and the results
of such evaluations were reported in 27 % of reviews. One
quarter of SRMAs reported using a published guideline or
checklist (or an author-modified version) for this purpose.
Quality scores were used in 21 % of reviews. Publication bias
was evaluated in 71% of reviews, most commonly (over 40%
of reviews) using a funnel chart. Some evidence of publication
bias was found in 31 % of reviews.
Results, Discussion, and Conclusions Nearly all reviews
presented characteristics of underlying studies in summary
tables (96 %), and most illustrated pooled effects using forest
plots (85 %). Uncertainty estimates were provided along with
summary effect measures in all 48 reviews. Most SRMAs
either examined one study design only (or predominantly) or
stratified and reported results by study design category. Efforts
of underlying studies to examine confounding, case selection,
and bias were evaluated and discussed in 58 % of reviews and
partially discussed in an additional 21 % of reviews. Thirty-
five percent of reviews explored reasons for observed negative
or no-effect findings in underlying studies.
Limitations were substantially discussed in 77 % of re-
views. Sources of bias and error were raised in this context
in 65 % of reviews, while exposure heterogeneity was raised
as a limitation in 77 % of reviews. Future EH research recom-
mendations were made in 96% of reviews. On the other hand,
generalizability was discussed in just 33 % of reviews, while
EH practice, policy, and improved study-reporting recommen-
dations were made in only 21, 25, and 19 % of reviews.
Discussion
In this systematic review of EH SRMAs published through
mid-2013 comparing methods employed to available guide-
lines, we found 48 studies using both SR and MA techniques
examining associations of low-dose environmental chemicals
and adverse health outcomes in general populations. The ma-
jority of these reviews were published since 2009, indicating
rapid recent uptake of SRMA methods in EH. Nearly half of
reviews examined associations between air pollution (indoor
and outdoor) exposures and respiratory or CVD outcomes.
Over one quarter evaluated associations between various
chemical exposures and cancer outcomes. In contrast, we
found few SRMAs for many metals (except for arsenic and
lead) and POPs, and none for chemicals of more recent inter-
est such as endocrine disruptors. Neurological, immune, and
endocrine-related outcomes and upstream effects were also
infrequently addressed. Many SRMAs noted that underlying
studies were largely from high-income countries (although
several covered China only and studies of indoor air pollution
were often in developing countries). These findings are broad-
ly consistent with a recent WHO review aimed at estimating
the disease burden from chemicals, which found that the larg-
est documentable burden was due to indoor solid fuel smoke
and outdoor air pollution (along with secondhand tobacco
smoke, not included in our review), but concluded that many
chemicals with known health effects could not be included
due to lack of meta-analyses providing pooled estimates [2].
High-quality epidemiologic studies and meta-analyses on
those missing chemicals are needed in order to more accurate-
ly estimate the burden of disease related to environmental
exposures.
Reported pooled results were mainly positive and statisti-
cally significant. Although some observed associations were
not large in magnitude, in many cases strong consistency was
noted across numerous studies and dose-response relation-
ships were observed, increasing confidence in the results.
Moreover, the risks often involved very large potentially ex-
posed populations: Solid fuels are estimated to be used by half
the world’s population; outdoor air pollution affects hundreds
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of millions of urban dwellers globally, and disinfection by-
products and arsenic in water supplies affect millions.
The techniques of SRMA can be useful in synthesizing
scientific information provided study goals are well-defined
and the methods used are sound [13]. In this review compar-
ing actual use of SRMA methods in EH with available guide-
lines, we found both strengths and weaknesses. Among
strengths, we found a high degree of concordance of SRMAs
with many elements of general published guidance such as
defining ex-ante selection criteria, reporting health outcome
ascertainment data and combining health outcomes that were
largely comparable, testing for heterogeneity among studies
using a statistical test, appropriately combining using a
random-effect model in the presence of heterogeneity, and
providing forest plots illustrating pooled effects. Most reviews
pursued to some extent unbundling of heterogeneity sources
across studies, either through stratification or meta-regression,
although in many cases, this was limited. Most discussed
some limitations, including causes of heterogeneity, error
and bias, and most evaluated publication bias. Nearly all pro-
vided recommendations for future research.
However, we also identified reporting and methodological
shortcomings in the EH SRMA literature reviewed that we
divide into two broad categories: (i) weaknesses with respect
to general SRMA reporting guidelines, including up-front
problem formulation and implications for generalizability
and policy; and in search, selection and extraction methods;
and (ii) weaknesses in methods reflecting specificities of EH,
including exposure measurement, and evaluation of other
quality and risk-of-bias parameters, particularly confounders.
General SRMA Guidelines
Goal Statement and Implications One of the principle re-
quirements of an SRMA is identification of a well-defined
research question, while among key SRMA features are their
ability to establish whether findings are consistent and gener-
alizable across populations, and to provide an evidence base
for policy development. Some SRMA did provide well-
defined goal statements and discuss generalizability, including
subsequent relevance for policy and practice. For example, in
the context of solid fuel IAP, one review identified at the
outset childhood respiratory infection prevention strategies
and concluded that, despite the review’s finding of observed
heterogeneity in IAP exposure and study designs, consistent
mounting evidence warranted their enhanced application [19].
However, we found that the large majority of SRMAs did not
do so. Strong, clear goal statements were present in just over
half of reviews. Generalizability of findings to other popula-
tions, and implications for policy, were discussed in a small
minority of reviews. EH SRMAs provide an opportunity for
enhancing policy and practice relevance of science findings at
a time when the field of EH risk assessment is shifting toward
greater attention to up-front problem formulation and its inte-
gration with policy- and decision-making [15•, 67]. This op-
portunity is currently under-utilized.
Search, Selection, and ExtractionWhile searches were gen-
erally well reported, their scope was often limited to one or
two databases, language was often restricted, and time hori-
zons were in some cases short. Unpublished materials were
sought in less than one third of reviews, while research sug-
gests that the grey literature is important in identifying studies
[68]. This suggests that some EH SRMAs may be biased
toward recent English language studies indexed in Medline.
This is also reflected in the finding that approximately half of
the reviews that examined publication bias found some evi-
dence of it. Increased use of databases available international-
ly and eliminating language restrictions (particularly with the
goal of identifying studies in low- and middle-income coun-
tries) are recommended. In addition, while peer review helps
ensure high-quality SRMAs, examination of the grey litera-
ture can help identify relevant peer-reviewed papers. Less than
half of reviews described procedures to avoid overlapping
populations or provided a PRISMA-recommended flow dia-
gram, suggesting some lack of transparency and replicability
in study selection. Journal space limitations are likely partly
responsible, as such features may have been undertaken and
not reported. A solution employed by several SMRAs [34, 36]
is providing standard SRMA elements as supplemental mate-
rial. Nearly half of reviews did not report the recommended
two or more independent reviewers while use of piloted ex-
traction forms was reported by a minority of studies, suggest-
ing potential for risk of error in data extraction. This also raises
the issue of SRMA resource intensity. Alternatives such as an
error-check procedure [20] or a second independent reviewer
extracting a random sample of studies [69] may be options to
explore. While their validity has yet to be determined, such
approaches may help address the trade-off between limited
resources and risk of error.
SRMA Guidelines Specific to EH
Exposure Measurement Exposure characterization was re-
ported to be a key source of between-study heterogeneity in
the majority of SRMAs. Although nearly all reviews com-
bined underlying studies whose exposure metrics were largely
similar, these metrics were deemed not fully comparable in
nearly two thirds of reviews. Exposure metrics commonly
used indirect proxies and relied on non-individual measures
and self-report, with OAP and metal exposure characteriza-
tions more broadly consistent with recommendations than the
other three chemical categories. Only a few reviews discussed
the likely direction of potential exposure-related error or bias;
such insights are useful additions to SRMAs. Some studies
not included in this review have concluded that exposure
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heterogeneity was sufficient to make combining unadvisable,
e.g., in the case of risk assessment for PCBs [70]. The lack of
updated, widely endorsed EH-specific guidelines for SRMA
may be one factor in the observed inconsistency in exposure
metrics; a well-disseminated EH SRMA consensus reporting
statement with clear principles regarding exposure measure-
ment would be an important contribution. These findings also
highlight the potential role for SRMAs in recommending stan-
dard practices for exposure measurement protocols in under-
lying studies. While several SRMAs provided such recom-
mendations [27, 47], this opportunity is under-utilized.
Other Sources of Bias While most reviews extracted data
on the covariates adjusted for in underlying studies and
reported adjusted rather than crude effect estimates, nearly
one quarter did not clearly identify potential confounders,
and in most reviews underlying studies adjusted for sets
of confounders that differed (e.g., key confounders such
as smoking status were often missing). More broadly,
quality (standards and reporting) and/or risk-of-bias (in-
ternal validity based on study design considerations) eval-
uations were undertaken in less than 40 % of reviews
(though the percentage increased over the time-period ex-
amined). Many additional SRMAs examined specific
quality- and bias-related issues in their Discussion sec-
tions; however, without the structure of a formalized qual-
ity evaluation, the analysis may be less transparent, sys-
tematic, and thorough. Quality scores, discouraged in
guidelines for their potential to add subjective bias, were
used in half of quality evaluations undertaken, and 11 %
percent of SRMAs reported performing quality assess-
ments but did not report their findings. Journal space con-
straints may have contributed to the latter outcome, and
use of supplemental information files may be a partial
solution. As in the case of exposure measurement, clear
EH-specific standards for reporting quality and risk-of-
bias evaluations would be a substantial contribution.
This is the first study to our knowledge to systematically re-
view the EH SRMA literature comparing methods used in
practice with guidance documents. A similar review of
SRMAs in the occupational health (OH) field identified 60
OH SRMAs examining mainly cancer outcomes and found
limitations and inconsistencies in exposure characterization
and inadequate and unclear adjustment for confounders [71],
findings generally consistent with ours. Unlike our study, that
review found many OH SRMAs used fixed effects models
even in the presence of substantial statistically confirmed het-
erogeneity. A review of SRMA in psychiatric epidemiology
found substantial heterogeneity among studies and noted par-
ticularly wide variety and poor comparability of outcome
measurement instruments [72], while a recent review of risk-
of-bias assessments in epidemiological studies found that
assessment conclusions were often poorly integrated into
study findings [73], both broadly consistent with our results.
Our meta-review is subject to certain limitations. Our
search may not have identified all published EH
SRMAs during the search period; however, it was de-
signed to cast a wide net and incorporated several strat-
egies to maximize location of all relevant studies. Our
quality review checklist was derived from guidelines
available during the period of our search. In order to
derive a checklist of reasonable length, we left out ele-
ments that could have been included; however, we be-
lieve that a slightly different list of items is likely to
have resulted in similar overall findings. Because the
SRMAs in our study covered a wide range of chemical
exposures and health outcomes, our findings are at a
high level of aggregation; focus on more specific
exposure-outcome associations would allow for more
in-depth evaluation. One such review of methods and
reporting in 16 SRMAs of EH and OH exposures and
pregnancy outcomes identified shortcomings primarily
related to exposure misclassification and confounding
[74], aligning broadly with our findings.
In addition, our study was limited to epidemiological stud-
ies in humans. In EH, many decisions are driven by animal-
based and cellular-based toxicology experiments, usually in
contexts where human studies are limited and/or difficult to
carry out. While a few SRMAs reviewed both the toxicology
and epidemiology literature [27], the vast majority did not. It
was beyond the scope of this review to examine the toxico-
logical literature; however, one such review found that while
use of SR methods was adequate, application of MA methods
was weak [75]; an updated animal review would be useful in
the future, making use of the reporting tools and risk-of-bias
criteria currently under development [76].
Our review is broadly consistent with recent efforts at re-
finement and development of EH SRMA tools by NIEHS/
NTP [14•], EPA/IRIS [15•], and the Navigation Guide [17•].
Among the aims of these newer approaches is to go a step
beyond evaluating reporting quality to designating a confi-
dence level for EH evidence, based on the strength of inherent
underlying study design, with adjustments made for factors
that reduce confidence (such as presence of bias in exposure
measurement and potential unadjusted confounding) and fac-
tors that enhance confidence (such as existence of dose-
response relationships, consistency in observed effects, and
large magnitudes of effect) [14•]. Our study findings support
these efforts by demonstrating gaps and shortcomings in ex-
posure and risk-of-bias assessment in the published literature
and by suggesting the contribution to improvements in these
areas that could be made by tailored EH SRMA guidelines. It
was not the goal of our study to conclude with strength-of-
evidence findings for published EH SRMAs; however, use of
the emerging tools for this purpose could add to the literature.
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Conclusion
In this meta-review of published EH SRMAs, we found
methods and reporting largely conform to available gen-
eral guidelines. However, there were important excep-
tions (including in problem formulation, policy implica-
tions, and search, selection, and extraction); moreover,
we found that SRMAs reflected lower awareness of and
poorer conformity with available guidelines applicable
to EH studies (particularly exposure measurement and
more general risk-of-bias assessment). Many journals
have incorporated PRISMA and MOOSE statements into
their author guidelines. As a continuation of refinements
to SRMA methods for observational studies, we recom-
mend development of a consensus statement of defini-
tive guidelines for EH SRMAs that is published, well-
disseminated, and adopted by journals as guidance to
study authors and peer reviewers.
Even with the design, methods, and reporting weaknesses
observed, the EH SRMAs examined in this review point to
broad trends in the EH evidence base, including policy prior-
ities involving large populations (e.g., risk of lung cancer,
COPD, and child respiratory infection associated with indoor
solid fuel smoke exposure; CVD risks associated with outdoor
PM2.5 exposure and arsenic); areas of apparent lack of signif-
icant associations (e.g., DDE and breast cancer; disinfection
by-products, and some birth outcomes); and gaps in the evi-
dence base for certain chemicals and health outcomes (e.g.,
endocrine disruptors, some metals, and POPs) and popula-
tions (e.g., low- and middle-income countries for exposures
different from indoor air pollution). We recommend a regular-
ly updated meta-review of the EH epidemiological SRMA
literature with the goal of identifying trends in evidence (in-
cluding strength-of-evidence assessments applying the emerg-
ing tools), identifying gaps and research priorities, and stock-
taking of methods and reporting quality.
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